Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Health Catalyst Inc shares valued at $23,891 were sold by Landry Benjamin on Jun 05 ’25. At $3.94 per share, Landry Benjamin sold 6,057 shares. The insider’s holdings dropped to 151,125 shares worth approximately $0.6 million following the completion of this transaction.
Also, BENJAMIN LANDRY purchased 6,057 shares, netting a total of over 23,925 in proceeds.
Before that, Benjamin Landry had added 3,255 shares to its account. In a trade valued at $11,831, the Officer bought Health Catalyst Inc shares for $3.63 each.
As published in a research note from Evercore ISI on April 09, 2025, Health Catalyst Inc [HCAT] has been rated down from an Outperform to an In-line. Analysts at KeyBanc Capital Markets upgraded the stock from ‘”a Sector weight”‘ to ‘”an Overweight”‘ outlook in a report released in early January. As of April 10, 2024, KeyBanc Capital Markets has decreased its “an Overweight” rating to a “Sector weight” for HCAT. Earlier on January 03, 2024, Evercore ISI upgraded its rating. Their new recommendation was “an Outperform” for HCAT stock which previously was a “an In-line”.
Analyzing HCAT Stock Performance
On last trading session,, Health Catalyst Inc [NASDAQ: HCAT] rose 0.51% to $3.98. The stock’s lowest price that day was $3.82, but it reached a high of $4.2 in the same session. During the last five days, there has been a surge of approximately 3.65%. Over the course of the year, Health Catalyst Inc shares have dropped approximately -43.71%.
Support And Resistance Levels for Health Catalyst Inc (HCAT)
RSI (Relative Strength Index) is 50.18 on the 14-day chart, showing neutral technical sentiment.
Is Health Catalyst Inc subject to short interest?
Stocks of Health Catalyst Inc saw a sharp rise in short interest on 2025-05-30 jumping by 43293.0 shares to 3.19 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 3.14 million shares. A jump of 1.36% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 6.32 of the overall float, the days-to-cover ratio (short ratio) jumped to 6.32.
Which companies own the most shares of Health Catalyst Inc (HCAT)?
In terms of Health Catalyst Inc share price expectations, FactSet research, analysts set an average price target of 5 in the next 12 months, up nearly 26.26% from the previous closing price of $3.96. Analysts anticipate Health Catalyst Inc stock to reach 7 by 2025, with the lowest price target being 5. In spite of this, 11 analysts ranked Health Catalyst Inc stock as Buy at the end of 2025. On January 03, 2024, Barclays assigned a price target of “an Overweight” to the stock and initiated coverage with a $14.
